L-arginine infusion increases basal but not activated cerebral blood flow in humans.

D C Reutens, M D McHugh, P J Toussaint, A C Evans, A Gjedde, E Meyer, D J Stewart

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Resumé

Udgivelsesdato: 1997-Mar
OriginalsprogEngelsk
TidsskriftJournal of Cerebral Blood Flow and Metabolism
Vol/bind17
Udgave nummer3
Sider (fra-til)309-15
Antal sider6
ISSN0271-678X
DOI
StatusUdgivet - 1997
Udgivet eksterntJa

Fingeraftryk

Nitric Oxide
Citrulline
Insulin

Citer dette

Reutens, D C ; McHugh, M D ; Toussaint, P J ; Evans, A C ; Gjedde, A ; Meyer, E ; Stewart, D J. / L-arginine infusion increases basal but not activated cerebral blood flow in humans. I: Journal of Cerebral Blood Flow and Metabolism. 1997 ; Bind 17, Nr. 3. s. 309-15.
@article{62ae01aff70b40c1b32559c1e3ba54db,
title = "L-arginine infusion increases basal but not activated cerebral blood flow in humans.",
abstract = "Nitric oxide is a potent vasodilator. Infusion of its precursor, L-arginine, results in increased cerebral blood flow (CBF) in experimental animals. We examined the effects of L-arginine infusion on CBF in humans using positron emission tomography and the quantitative H2(15)O method. Six subjects received 500 ml of 0.9{\%} NaCl solution, and six subjects received an infusion of L-arginine (16.7 mg/kg/min; 500 mg/kg). Before and after the i.v. infusion, paired CBF measurements were performed at baseline and with vibrotactile stimulation of the right hand. In scans performed without vibrotactile stimulation, mean whole-brain CBF increased from 34.9 +/- 3.7 ml 100 g-1 min-1 to 38.2 +/- 4.4 ml 100 g-1 min-1. (9.5{\%}; p < 0.005) after L-arginine infusion. The temporal pattern of CBF changes differed from that of plasma growth hormone and insulin levels and of arterial pH. In contrast, in the saline group, mean whole-brain CBF did not change significantly (35.8 +/- 5.9 ml 100 g-1 min-1 to 35.9 +/- 6.4 ml 100 g-1 min-1; 0.3{\%}). Vibrotactile stimulation produced significant focal increases in CBF, which were unaffected by L-arginine infusion. L-arginine infusion was associated with an increase in plasma L-citrulline, a byproduct of nitric oxide synthesis.",
author = "Reutens, {D C} and McHugh, {M D} and Toussaint, {P J} and Evans, {A C} and A Gjedde and E Meyer and Stewart, {D J}",
year = "1997",
doi = "10.1097/00004647-199703000-00008",
language = "English",
volume = "17",
pages = "309--15",
journal = "Journal of Cerebral Blood Flow and Metabolism",
issn = "0271-678X",
publisher = "SAGE Publications",
number = "3",

}

L-arginine infusion increases basal but not activated cerebral blood flow in humans. / Reutens, D C; McHugh, M D; Toussaint, P J; Evans, A C; Gjedde, A; Meyer, E; Stewart, D J.

I: Journal of Cerebral Blood Flow and Metabolism, Bind 17, Nr. 3, 1997, s. 309-15.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

TY - JOUR

T1 - L-arginine infusion increases basal but not activated cerebral blood flow in humans.

AU - Reutens, D C

AU - McHugh, M D

AU - Toussaint, P J

AU - Evans, A C

AU - Gjedde, A

AU - Meyer, E

AU - Stewart, D J

PY - 1997

Y1 - 1997

N2 - Nitric oxide is a potent vasodilator. Infusion of its precursor, L-arginine, results in increased cerebral blood flow (CBF) in experimental animals. We examined the effects of L-arginine infusion on CBF in humans using positron emission tomography and the quantitative H2(15)O method. Six subjects received 500 ml of 0.9% NaCl solution, and six subjects received an infusion of L-arginine (16.7 mg/kg/min; 500 mg/kg). Before and after the i.v. infusion, paired CBF measurements were performed at baseline and with vibrotactile stimulation of the right hand. In scans performed without vibrotactile stimulation, mean whole-brain CBF increased from 34.9 +/- 3.7 ml 100 g-1 min-1 to 38.2 +/- 4.4 ml 100 g-1 min-1. (9.5%; p < 0.005) after L-arginine infusion. The temporal pattern of CBF changes differed from that of plasma growth hormone and insulin levels and of arterial pH. In contrast, in the saline group, mean whole-brain CBF did not change significantly (35.8 +/- 5.9 ml 100 g-1 min-1 to 35.9 +/- 6.4 ml 100 g-1 min-1; 0.3%). Vibrotactile stimulation produced significant focal increases in CBF, which were unaffected by L-arginine infusion. L-arginine infusion was associated with an increase in plasma L-citrulline, a byproduct of nitric oxide synthesis.

AB - Nitric oxide is a potent vasodilator. Infusion of its precursor, L-arginine, results in increased cerebral blood flow (CBF) in experimental animals. We examined the effects of L-arginine infusion on CBF in humans using positron emission tomography and the quantitative H2(15)O method. Six subjects received 500 ml of 0.9% NaCl solution, and six subjects received an infusion of L-arginine (16.7 mg/kg/min; 500 mg/kg). Before and after the i.v. infusion, paired CBF measurements were performed at baseline and with vibrotactile stimulation of the right hand. In scans performed without vibrotactile stimulation, mean whole-brain CBF increased from 34.9 +/- 3.7 ml 100 g-1 min-1 to 38.2 +/- 4.4 ml 100 g-1 min-1. (9.5%; p < 0.005) after L-arginine infusion. The temporal pattern of CBF changes differed from that of plasma growth hormone and insulin levels and of arterial pH. In contrast, in the saline group, mean whole-brain CBF did not change significantly (35.8 +/- 5.9 ml 100 g-1 min-1 to 35.9 +/- 6.4 ml 100 g-1 min-1; 0.3%). Vibrotactile stimulation produced significant focal increases in CBF, which were unaffected by L-arginine infusion. L-arginine infusion was associated with an increase in plasma L-citrulline, a byproduct of nitric oxide synthesis.

U2 - 10.1097/00004647-199703000-00008

DO - 10.1097/00004647-199703000-00008

M3 - Journal article

C2 - 9119904

VL - 17

SP - 309

EP - 315

JO - Journal of Cerebral Blood Flow and Metabolism

JF - Journal of Cerebral Blood Flow and Metabolism

SN - 0271-678X

IS - 3

ER -